See veebileht kasutab küpsiseid kasutaja sessiooni andmete hoidmiseks. Veebilehe kasutamisega nõustute ETISe kasutustingimustega. Loe rohkem
Olen nõus

Piret Arukuusk

https://www.etis.ee/CV/Piret_Arukuusk/est
piret.arukuusk@ut.ee

Teenistuskäik

Töökohad ja ametid
01.01.2016–...   
Tartu Ülikool, Loodus- ja täppisteaduste valdkond, tehnoloogiainstituut, peptiidikeemia teadur (1,00)
01.09.2015–31.12.2015   
Tartu Ülikool, Loodus- ja tehnoloogiateaduskond, Tartu Ülikooli Tehnoloogiainstituut, peptiidikeemia teadur (1,00)
15.11.2013–31.07.2015   
Tartu Ülikool, Loodus- ja tehnoloogiateaduskond, Tartu Ülikooli Tehnoloogiainstituut, molekulaarse biotehnoloogia teadur (1,00)
01.09.2009–14.11.2013   
Tartu Ülikool, Loodus- ja tehnoloogiateaduskond, Tartu Ülikooli Tehnoloogiainstituut, spetsialist (1,00)
 
 
Haridustee
2011–2013   
Tartu Ülikool, doktorant
1982–1987   
Tartu Ülikool, keemia
1971–1982   
Tartu 2. Keskkool

Kvalifikatsioon

Teaduskraadid
Piret Arukuusk, doktorikraad, 2013, (juh) Ülo Langel, NickFects - novel cell-penetrating peptides. Design and uptake mechanism (NcikFectid - uued rakku sisenevad peptiidid. Disain ja sisenemismehanism), Tartu Ülikool.
Piret Arukuusk, magistrikraad, 1987, (juh) , Fosfolipaas A2, Neuraminidaasi ja proteaaside mõju membraanseotud ja solubiliseeritud muskariinsele retseptorile, Tartu Ülikool.
 
 
Teadustöö põhisuunad
ETIS KLASSIFIKAATOR: 1. Bio- ja keskkonnateadused; 1.12. Bio- ja keskkonnateadustega seotud uuringud, näiteks biotehnoloogia, molekulaarbioloogia, rakubioloogia, biofüüsika, majandus- ja tehnoloogiauuringud; CERCS KLASSIFIKAATOR: T360 Biokeemiatehnoloogia

Jooksvad projektid

Lõppenud projektid

Juhendatud väitekirjad

Publikatsioonid

Klass
Aasta
Publikatsioon
 
3.1.
2020
Arukuusk, Piret; Langel, Ülo (2020). Synthesis of NickFects, a New Family of CPPs, by Solid-Phase Peptide Synthesis. In: Waleed M. HusseinMariusz SkwarczynskiIstvan Toth (Ed.). Peptide Synthesis (239−247). Springler. (Methods in Molecular Biology). DOI: 10.1007/978-1-0716-0227-0_16.
1.1.
2019
Porosk, Ly; Arukuusk, Piret; Põhako, Kaisa; Kurrikoff, Kaido; Kiisholts, Kristina; Padari, Kärt; Pooga, Margus; Langel, Ülo (2019). Enhancement of siRNA transfection by the optimization of fatty acid length and histidine content in the CPP. Biomaterials Science. DOI: 10.1039/C9BM00688E.
3.1.
2019
Padari, K., Porosk, L., Arukuusk, P., Pooga, M. (2019). Characterization of Peptide/oligonucleotide Complexes Using Electron Microscopy, Dynamic Light Scattering and Protease Resistance Assay. In: Olof Gissberg, Rula Zain, and Karin E. Lundin (Ed.). Methods Mol Biol (127−139). Humana Press.
1.1.
2018
Freimann, Krista; Arukuusk, Piret; Kurrikoff, Kaido; Pärnaste, Ly; Raid, Raivo; Piirsoo, Andres; Pooga, Margus; Lange, Ülo (2018). Formulation of stable and homogenous cell penetrating peptide NF55 nanoparticles for efficient gene delivery in vivo. Molecular Therapy — Nucleic Acids, 10, 28−35. DOI: 10.1016/j.omtn.2017.10.011.
1.1.
2017
Juks, C.; Lorents, A.; Arukuusk, P.; Langel, Ü.; Pooga, M. (2017). Cell-penetrating peptides recruit type A scavenger receptors to the plasma membrane for cellular delivery of nucleic acids. The FASEB Journal, 31 (3), 975−988. DOI: 10.1096/fj.201600811r.
1.1.
2017
Pärnaste, Ly; Arukuusk, Piret; Langel, Kent; Tenson, Tanel; Langel, Ülo (2017). The formation of nanoparticles between small interfering RNA and amphipathic cell-penetrating peptides. Molecular Therapy — Nucleic Acids, 7, 1−10. DOI: 10.1016/j.omtn.2017.02.003.
1.1.
2017
Kurrikoff, Kaido; Veiman, Kadi-Liis; Künnapuu, Kadri; Peets, Elin Madli; Lehto, Tõnis; Pärnaste, Ly; Arukuusk, Piret; Langel, Ülo (2017). Effective in vivo gene delivery with reduced toxicity, achieved by charge and fatty acid -modified cell penetrating peptide. Scientific Reports, 7 (1), 17056−17056. DOI: 10.1038/s41598-017-17316-y.
1.1.
2016
Margus, Helerin; Arukuusk, Piret; Langel, Ülo; Pooga, Margus (2016). Characteristics of Cell-Penetrating Peptide/Nucleic Acid Nanoparticles. Molecular Pharmaceutics, 13 (1), 172−179. DOI: 10.1021/acs.molpharmaceut.5b00598.
1.1.
2016
Pärnaste, Ly; Arukuusk, Piret; Zagato, Elisa; Braeckmans, Kevin; Langel, Ülo (2016). Methods to follow intracellular trafficking of cell-penetrating peptides. Journal of Drug Targeting, 24 (6), 508−519.10.3109/1061186X.2015.1095194.
1.1.
2016
Pae, J.; Liivamägi, L.; Etverk, I.; Lubenets, D.; Arukuusk, P.; Langel, Ü.; Pooga, M. (2016). Glycosaminoglycans are required for translocation of amphipathic cell-penetrating peptides across membranes. Biochimica et Biophysica Acta (BBA) - Biomembranes, 1858 (8), 1860−1867. DOI: 10.1016/j.bbamem.2016.04.010.
1.1.
2016
Freimann, Krista; Arukuusk, Piret; Kurrikoff, Kaido; Vasconcelos, Luís Daniel Ferreira; Veiman, Kadi-Liis; Uusna, Julia; Margus, Helerin; Garcia-Sosa, Alfonso T; Pooga, Margus; Langel, Ülo (2016). Optimization of in vivo DNA delivery with NickFect peptide vectors. Journal of controlled release : official journal of the Controlled Release Society, 241, 135−143. DOI: 10.1016/j.jconrel.2016.09.022.
1.1.
2016
Kivi, Rait; Solovjova, Karina; Haljasorg, Tõiv; Arukuusk, Piret; Järv, Jaak (2016). Allosteric Effect of Adenosine Triphosphate on Peptide Recognition by 3'5'-Cyclic Adenosine Monophosphate Dependent Protein Kinase Catalytic Subunits. The Protein Journal, 35 (6), 459−466. DOI: 10.1007/s10930-016-9691-9.
1.1.
2015
Arukuusk, P.; Pärnaste, L.; Hällbrink, M.; Langel, Ü. (2015). Pepfects and nickfects for the intracellular delivery of nucleic acids (Methods in Molecular Biology). Methods in molecular biology, 1324, 303−315.10.1007/978-1-4939-2806-4_19.
1.1.
2015
Juks, C.; Padari, K.; Margus, H.; Kriiska, A.; Etverk, I.; Arukuusk, P.; Koppel, K.; Ezzat, K.; Langel, Ü.; Pooga, M. (2015). The role of endocytosis in the uptake and intracellular trafficking of PepFect14-nucleic acid nanocomplexes via class A scavenger receptors. Biochimica et Biophysica Acta (BBA) - Biomembranes, 1848 (12), 3205−3216. DOI: 10.1016/j.bbamem.2015.09.019.
1.1.
2014
Vasconcelos, Luis; Madani, Fatemeh; Arukuusk, Piret; Pärnaste, Ly; Gräslund, Astrid, Langel, Ülo (2014). Effects of cargo molecules on membrane perturbation caused by transportan10 based cell-penetrating peptides. Biochimica et Biophysica Acta, 1838 (12), 3118−3129.10.1016/j.bbamem.2014.08.011.
1.1.
2014
Pae, J.; Säälik, P.; Liivamägi, L.; Lubenets, D.; Arukuusk, P.; Langel, Ü.; Pooga, M. (2014). Translocation of cell-penetrating peptides across the plasma membrane is controlled by cholesterol and microenvironment created by membranous proteins. Journal of Controlled Release, 192, 103−113. DOI: 10.1016/j.jconrel.2014.07.002.
1.1.
2014
Rytkönen, Jussi; Arukuusk, Piret; Xu, Wujun; Kurrikoff, Kaido; Langel, Ülo; Lehto, Vesa-Pekka; Närvänen, Ale (2014). Porous Silicon–Cell Penetrating Peptide Hybrid Nanocarrier for Intracellular Delivery of Oligonucleotides. Molecular Pharmaceutics, 11 (2), 382−390. DOI: 10.1021/mp4002624.
5.1.
2014
Margus, H.; Arukuusk, P.; Langel, Ü.; Pooga, M. (2014). Morphology of cell-penetrating peptide-nucleic acid nanoparticles and their intracellular trafficking. FEBS JOURNAL, 281, SI: FEBS EMBO 2014, Paris. Wiley-Blackwell, 413−414.
1.1.
2013
Arukuusk, P; Pärnaste, L.; Margus, H.; Eriksson, J.; Vasconcelos, L.;.Padari, K.; Pooga, M.; Langel, Ü. (2013). Differential endosomal pathways for radically modified peptide vectors. Bioconjugate Chemistry, 24 (10), 1721−1732. DOI: 10.1021/bc4002757.
1.1.
2013
Arukuusk, P.; Pärnaste, L.; Oskolkov, N.; Copolovici, D. M.; Margus, H.; Padari, K.; Möll, K.; Maslovskaja, J.; Tegova, R.; Kivi, G.; Tover, A.; Pooga, M.; Ustav, M.; Langel, Ü. (2013). New generation of efficient peptide-based vectors, NickFects, for the delivery of nucleic acids. Biochimica et Biophysica Acta (BBA) - Biomembranes, 1828 (5), 1365−1373. DOI: 10.1016/j.bbamem.2013.01.011.
1.1.
2013
Veiman, K.L.; Mäger, I.; Ezzat, K.; Margus, H.; Lehto, T.; Langel, K.; Kurrikoff, K.; Arukuusk, P.; Suhorutšenko, J.; Padari, K.; Pooga, M.; Lehto, T.; Langel, Ü. (2013). PepFect14 peptide vector for efficient gene delivery in cell cultures. Molecular Pharmaceutics, 10 (1), 199−210. DOI: 10.1021/mp3003557.
1.1.
2011
Suhorutšenko, J.; Oskolkov, N.; Arukuusk, P.; Kurrikoff, K.; Eriste, E.; Copolovici, D.-M.; Langel, Ü. (2011). Cell-Penetrating Peptides, PepFects, Show No Evidence of Toxicity and Immunogenicity In Vitro and In Vivo. Bioconjugate Chemistry, 22 (11), 2255−2262. DOI: 10.1021/bc200293d.
1.1.
2011
Oskolkov, N.; Arukuusk, P.; Copolovici, D.-M.; Lindberg, S.; Margus, H.; Padari, K.; Pooga, M.; Langel, Ü. (2011). NickFects, Phosphorylated Derivatives of Transportan 10 for Cellular Delivery of Oligonucleotides. International Journal of Peptide Research and Therapeutics, 17 (2), 147−157. DOI: 10.1007/s10989-011-9252-1.
1.1.
2010
Langel, K; Lindberg, S; Copolovici, D; Arukuusk, P; Sillard, R; Langel, Ü. (2010). Novel fatty acid modifications of transportan 10. International Journal of Peptide Research and Therapeutics, 16 (4), 247−255.10.1007/s10989-010-9224-x.
5.1.
2010
Suhorutsenko, J.; Copolovici, D. M.; Eriste, E.; Oskolkov, N.; Arukuusk, P.; Langel, Ü. (2010). New cell-penetrating peptides induce no inflammatory response in antigen-presenting cell lines. Scandinavian Journal of Immunology, 71, 508−509.
3.2.
1989
Järv, J.; Arukuusk, P.; Kõiv, A.; Rinken, A. (1989). Muscarinic receptor - biomembrane interaction. In: Kotyr ,A.; Skoda, J.; Paces, V.; Kostka, V. (Ed.). Highlights of Modern Biochemistry (1073−1082). . Praha: Zeist.

Tööstusomand

20.11.2020

Piret Arukuusk

https://www.etis.ee/CV/Piret_Arukuusk/eng
piret.arukuusk@ut.ee

Career

Institutions and positions
01.01.2016–...   
University of Tartu, Faculty of Science and Technology, Institute of Technology, Research Fellow in Peptide Chemistry (1,00)
01.09.2015–31.12.2015   
University of Tartu, Faculty of Science and Technology (old), Institute of Technology, University of Tartu, Research Fellow in Peptide Chemistry (1,00)
15.11.2013–31.07.2015   
University of Tartu, Faculty of Science and Technology (old), Institute of Technology, University of Tartu, Research Fellow in Molecular Biotechnology (1,00)
01.09.2009–14.11.2013   
University of Tartu, Faculty of Science and Technology (old), Institute of Technology, University of Tartu, Specialist (1,00)
 
 
Education
2011–2013   
Tartu University, PhD student
1982–1987   
University of Tartu, chemistry
1971–1982   
Tartu 2. Highschool

Qualifications

Academic degrees
Piret Arukuusk, Doctor's Degree, 2013, (sup) Ülo Langel, NickFects - novel cell-penetrating peptides. Design and uptake mechanism, University of Tartu.
Piret Arukuusk, Master's Degree, 1987, (sup) , Fosfolipaas A2, Neuraminidaasi ja proteaaside mõju membraanseotud ja solubiliseeritud muskariinsele retseptorile, University of Tartu.
 
 
Fields of research
ETIS CLASSIFICATION: 1. Biosciences and Environment; 1.12. Biotechnology, Molecular Biology, Cell Biology, Biophysics and Economic and Technological Research relating to Bio- and Environmental Sciences; CERCS CLASSIFICATION: T360 Biochemical technology
 
 

Projects in progress

Completed projects

Supervised dissertations

Publications

Category
Year
Publication
 
3.1.
2020
Arukuusk, Piret; Langel, Ülo (2020). Synthesis of NickFects, a New Family of CPPs, by Solid-Phase Peptide Synthesis. In: Waleed M. HusseinMariusz SkwarczynskiIstvan Toth (Ed.). Peptide Synthesis (239−247). Springler. (Methods in Molecular Biology). DOI: 10.1007/978-1-0716-0227-0_16.
1.1.
2019
Porosk, Ly; Arukuusk, Piret; Põhako, Kaisa; Kurrikoff, Kaido; Kiisholts, Kristina; Padari, Kärt; Pooga, Margus; Langel, Ülo (2019). Enhancement of siRNA transfection by the optimization of fatty acid length and histidine content in the CPP. Biomaterials Science. DOI: 10.1039/C9BM00688E.
3.1.
2019
Padari, K., Porosk, L., Arukuusk, P., Pooga, M. (2019). Characterization of Peptide/oligonucleotide Complexes Using Electron Microscopy, Dynamic Light Scattering and Protease Resistance Assay. In: Olof Gissberg, Rula Zain, and Karin E. Lundin (Ed.). Methods Mol Biol (127−139). Humana Press.
1.1.
2018
Freimann, Krista; Arukuusk, Piret; Kurrikoff, Kaido; Pärnaste, Ly; Raid, Raivo; Piirsoo, Andres; Pooga, Margus; Lange, Ülo (2018). Formulation of stable and homogenous cell penetrating peptide NF55 nanoparticles for efficient gene delivery in vivo. Molecular Therapy — Nucleic Acids, 10, 28−35. DOI: 10.1016/j.omtn.2017.10.011.
1.1.
2017
Juks, C.; Lorents, A.; Arukuusk, P.; Langel, Ü.; Pooga, M. (2017). Cell-penetrating peptides recruit type A scavenger receptors to the plasma membrane for cellular delivery of nucleic acids. The FASEB Journal, 31 (3), 975−988. DOI: 10.1096/fj.201600811r.
1.1.
2017
Pärnaste, Ly; Arukuusk, Piret; Langel, Kent; Tenson, Tanel; Langel, Ülo (2017). The formation of nanoparticles between small interfering RNA and amphipathic cell-penetrating peptides. Molecular Therapy — Nucleic Acids, 7, 1−10. DOI: 10.1016/j.omtn.2017.02.003.
1.1.
2017
Kurrikoff, Kaido; Veiman, Kadi-Liis; Künnapuu, Kadri; Peets, Elin Madli; Lehto, Tõnis; Pärnaste, Ly; Arukuusk, Piret; Langel, Ülo (2017). Effective in vivo gene delivery with reduced toxicity, achieved by charge and fatty acid -modified cell penetrating peptide. Scientific Reports, 7 (1), 17056−17056. DOI: 10.1038/s41598-017-17316-y.
1.1.
2016
Margus, Helerin; Arukuusk, Piret; Langel, Ülo; Pooga, Margus (2016). Characteristics of Cell-Penetrating Peptide/Nucleic Acid Nanoparticles. Molecular Pharmaceutics, 13 (1), 172−179. DOI: 10.1021/acs.molpharmaceut.5b00598.
1.1.
2016
Pärnaste, Ly; Arukuusk, Piret; Zagato, Elisa; Braeckmans, Kevin; Langel, Ülo (2016). Methods to follow intracellular trafficking of cell-penetrating peptides. Journal of Drug Targeting, 24 (6), 508−519.10.3109/1061186X.2015.1095194.
1.1.
2016
Pae, J.; Liivamägi, L.; Etverk, I.; Lubenets, D.; Arukuusk, P.; Langel, Ü.; Pooga, M. (2016). Glycosaminoglycans are required for translocation of amphipathic cell-penetrating peptides across membranes. Biochimica et Biophysica Acta (BBA) - Biomembranes, 1858 (8), 1860−1867. DOI: 10.1016/j.bbamem.2016.04.010.
1.1.
2016
Freimann, Krista; Arukuusk, Piret; Kurrikoff, Kaido; Vasconcelos, Luís Daniel Ferreira; Veiman, Kadi-Liis; Uusna, Julia; Margus, Helerin; Garcia-Sosa, Alfonso T; Pooga, Margus; Langel, Ülo (2016). Optimization of in vivo DNA delivery with NickFect peptide vectors. Journal of controlled release : official journal of the Controlled Release Society, 241, 135−143. DOI: 10.1016/j.jconrel.2016.09.022.
1.1.
2016
Kivi, Rait; Solovjova, Karina; Haljasorg, Tõiv; Arukuusk, Piret; Järv, Jaak (2016). Allosteric Effect of Adenosine Triphosphate on Peptide Recognition by 3'5'-Cyclic Adenosine Monophosphate Dependent Protein Kinase Catalytic Subunits. The Protein Journal, 35 (6), 459−466. DOI: 10.1007/s10930-016-9691-9.
1.1.
2015
Arukuusk, P.; Pärnaste, L.; Hällbrink, M.; Langel, Ü. (2015). Pepfects and nickfects for the intracellular delivery of nucleic acids (Methods in Molecular Biology). Methods in molecular biology, 1324, 303−315.10.1007/978-1-4939-2806-4_19.
1.1.
2015
Juks, C.; Padari, K.; Margus, H.; Kriiska, A.; Etverk, I.; Arukuusk, P.; Koppel, K.; Ezzat, K.; Langel, Ü.; Pooga, M. (2015). The role of endocytosis in the uptake and intracellular trafficking of PepFect14-nucleic acid nanocomplexes via class A scavenger receptors. Biochimica et Biophysica Acta (BBA) - Biomembranes, 1848 (12), 3205−3216. DOI: 10.1016/j.bbamem.2015.09.019.
1.1.
2014
Vasconcelos, Luis; Madani, Fatemeh; Arukuusk, Piret; Pärnaste, Ly; Gräslund, Astrid, Langel, Ülo (2014). Effects of cargo molecules on membrane perturbation caused by transportan10 based cell-penetrating peptides. Biochimica et Biophysica Acta, 1838 (12), 3118−3129.10.1016/j.bbamem.2014.08.011.
1.1.
2014
Pae, J.; Säälik, P.; Liivamägi, L.; Lubenets, D.; Arukuusk, P.; Langel, Ü.; Pooga, M. (2014). Translocation of cell-penetrating peptides across the plasma membrane is controlled by cholesterol and microenvironment created by membranous proteins. Journal of Controlled Release, 192, 103−113. DOI: 10.1016/j.jconrel.2014.07.002.
1.1.
2014
Rytkönen, Jussi; Arukuusk, Piret; Xu, Wujun; Kurrikoff, Kaido; Langel, Ülo; Lehto, Vesa-Pekka; Närvänen, Ale (2014). Porous Silicon–Cell Penetrating Peptide Hybrid Nanocarrier for Intracellular Delivery of Oligonucleotides. Molecular Pharmaceutics, 11 (2), 382−390. DOI: 10.1021/mp4002624.
5.1.
2014
Margus, H.; Arukuusk, P.; Langel, Ü.; Pooga, M. (2014). Morphology of cell-penetrating peptide-nucleic acid nanoparticles and their intracellular trafficking. FEBS JOURNAL, 281, SI: FEBS EMBO 2014, Paris. Wiley-Blackwell, 413−414.
1.1.
2013
Arukuusk, P; Pärnaste, L.; Margus, H.; Eriksson, J.; Vasconcelos, L.;.Padari, K.; Pooga, M.; Langel, Ü. (2013). Differential endosomal pathways for radically modified peptide vectors. Bioconjugate Chemistry, 24 (10), 1721−1732. DOI: 10.1021/bc4002757.
1.1.
2013
Arukuusk, P.; Pärnaste, L.; Oskolkov, N.; Copolovici, D. M.; Margus, H.; Padari, K.; Möll, K.; Maslovskaja, J.; Tegova, R.; Kivi, G.; Tover, A.; Pooga, M.; Ustav, M.; Langel, Ü. (2013). New generation of efficient peptide-based vectors, NickFects, for the delivery of nucleic acids. Biochimica et Biophysica Acta (BBA) - Biomembranes, 1828 (5), 1365−1373. DOI: 10.1016/j.bbamem.2013.01.011.
1.1.
2013
Veiman, K.L.; Mäger, I.; Ezzat, K.; Margus, H.; Lehto, T.; Langel, K.; Kurrikoff, K.; Arukuusk, P.; Suhorutšenko, J.; Padari, K.; Pooga, M.; Lehto, T.; Langel, Ü. (2013). PepFect14 peptide vector for efficient gene delivery in cell cultures. Molecular Pharmaceutics, 10 (1), 199−210. DOI: 10.1021/mp3003557.
1.1.
2011
Suhorutšenko, J.; Oskolkov, N.; Arukuusk, P.; Kurrikoff, K.; Eriste, E.; Copolovici, D.-M.; Langel, Ü. (2011). Cell-Penetrating Peptides, PepFects, Show No Evidence of Toxicity and Immunogenicity In Vitro and In Vivo. Bioconjugate Chemistry, 22 (11), 2255−2262. DOI: 10.1021/bc200293d.
1.1.
2011
Oskolkov, N.; Arukuusk, P.; Copolovici, D.-M.; Lindberg, S.; Margus, H.; Padari, K.; Pooga, M.; Langel, Ü. (2011). NickFects, Phosphorylated Derivatives of Transportan 10 for Cellular Delivery of Oligonucleotides. International Journal of Peptide Research and Therapeutics, 17 (2), 147−157. DOI: 10.1007/s10989-011-9252-1.
1.1.
2010
Langel, K; Lindberg, S; Copolovici, D; Arukuusk, P; Sillard, R; Langel, Ü. (2010). Novel fatty acid modifications of transportan 10. International Journal of Peptide Research and Therapeutics, 16 (4), 247−255.10.1007/s10989-010-9224-x.
5.1.
2010
Suhorutsenko, J.; Copolovici, D. M.; Eriste, E.; Oskolkov, N.; Arukuusk, P.; Langel, Ü. (2010). New cell-penetrating peptides induce no inflammatory response in antigen-presenting cell lines. Scandinavian Journal of Immunology, 71, 508−509.
3.2.
1989
Järv, J.; Arukuusk, P.; Kõiv, A.; Rinken, A. (1989). Muscarinic receptor - biomembrane interaction. In: Kotyr ,A.; Skoda, J.; Paces, V.; Kostka, V. (Ed.). Highlights of Modern Biochemistry (1073−1082). . Praha: Zeist.

Industrial property

20.11.2020

Otsi projekti

  • {{item.Name}}
Asutus on projekti finantseerija   Asutus on projekti teostaja  
  • {{searchListItem.Name}}
Kõik   Tavaprojektid   Ülemprojektid   Alamprojektid  
Uus Frascati (2015)
Uus ja vana Frascati (otsing uue järgi väljastab ka seotud vanad)
Kõik
Käimasolevad
Lõppenud
Algus
Hajus
Täpne
Lihtotsing Tühjenda
  • Leitud 6 kirjet
ProgrammLiikNumberNimiProjekti algusProjekti lõppVastutav täitjaAsutusFinantseerijapoolne rahastamine
MUUSLOTI11182T (3.2.0701.11-0016)Hepatiit C viiruse vastaste ravimikandidaatide väljatöötamise platvorm01.01.201231.12.2013Andres MeritsTartu Ülikool; Tartu Ülikool, Loodus- ja tehnoloogiateaduskond872 230,20 EUR
SFSF0180027s08Koespetsiifilised transportvektorid01.01.200831.12.2013Ülo LangelTartu Ülikool, Loodus- ja tehnoloogiateaduskond, Tartu Ülikooli Tehnoloogiainstituut600 272,61 EUR
TKSLTTI16143T (TK143)Molekulaarse Rakutehnoloogia Tippkeskus (TK143)01.01.201601.03.2023Tanel TensonTartu Ülikool, Loodus- ja täppisteaduste valdkond, tehnoloogiainstituut3 917 568,00 EUR
2.1.1.LLTTI19567 Rakku penetreeruvate peptiidide kasutamine transfektsioonireagendina01.10.201930.09.2020Kaido KurrikoffTartu Ülikool, Loodus- ja täppisteaduste valdkond, tehnoloogiainstituut160 033,90 EUR
IUTIUT20-26Trans-barrier targeting01.01.201431.12.2019Ülo LangelTartu Ülikool, Loodus- ja täppisteaduste valdkond, tehnoloogiainstituut889 200,00 EUR
ETFETF9438Uued meetodid therapeutikumide raku spetsiifiliseks sisestamiseks01.01.201201.12.2015Julia UusnaTartu Ülikool, Loodus- ja tehnoloogiateaduskond, Tartu Ülikooli Tehnoloogiainstituut46 440,00 EUR